GlassScriptPhysician profile
Sarah Jane Counts
NPI 1073833836
$109,477.34
in general payments reported to CMS, 2019-2025
8 companies · $7,155 in 2025
The $7,155 reported for 2025 was more than what 87% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $1,083 · 2021: $337 · 2022: $34K · 2023: $19K · 2024: $28K · 2025: $7,155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Education: $8,000 · Travel and Lodging: $6,647 · Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,253.61 |
| Education | $8,000.00 |
| Travel and Lodging | $6,646.87 |
| Food and Beverage | $1,214.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $49,788.79 | 2021-2025 | Monarch Platform |
| Intuitive Surgical, INC. | $42,351.63 | 2019-2024 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $17,102.63 | 2023-2025 | Monarch Platform, Monarch |
| Zimmer Biomet Holdings, INC. | $65.83 | 2022 | |
| Medtronic, INC. | $62.48 | 2023 | Gi Genius |
| Davol INC. | $56.52 | 2023 | Phasix Mesh |
| Merck Sharp & Dohme LLC | $25.26 | 2024 | Keytruda |
| Atricure, INC. | $24.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Counts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.